cancer - search results

We warmly invite you to delve into the April volume of North America Analysis, where we enjoy a multitude of insights from experts in the field from the region.

Find out here what makes the €10 million ERC Synergy Grant unique and valuable for academics seeking to push the boundaries of their fields.

Researchers from Carnegie Mellon University's Human-Computer Interaction Institute (HCII) have studied how AI in ICU will assist clinicians.

Dr. Ludivine Herman, Project Leader at immunotherapy specialist Imcyse, walks us through Neuoromyelitis optica facts & trends, the challenges of current therapies and the potential of immunotherapies.

How does eating a high-fat diet during pregnancy or in early life affect your health? Researchers tested on rat offspring to study how diet impacts future preferences.

New research reveals how both alcohol consumption and withdrawal have the potential to result in hypersensitivity and increased chronic pain.

Open Access Government provides a short introduction to biomedical research and innovation in the UK, including autism.

Open Access Government places care policy in Europe under the spotlight, including support for caregivers and those with rare diseases or cancer.

Open Access Government unpacks some of the research support that takes place in the National Research Foundation of Korea.

Type-2 cannabinoid receptor (CB2R) is a G-protein-coupled receptor (GPCR) and an essential element of the endocannabinoid system (ECS) [1].

NHS England has plans to merge data with private healthcare institutions to process and share information on healthcare activity.

Decision Intelligence helps government agencies to unify their data and improve mission-critical decision-making to drive better services.

It's time to welcome our April 2023 bumper digital publication. Here we deliver comprehensive policy analysis, including health & social care, research & innovation, digital transformation, government, finance, transport, energy, environment and agriculture.

The term “forever chemicals” has become part of the lexicon in lay science. This reflects the growing evidence that exposure to perfluoroalkyl substances (PFAS), a class of synthetic chemicals widely detected in our natural environment, our foods, and our bodies, is associated with adverse human health effects and harm...

Here, Doctor Peter J Houghton explains current therapies for childhood brain cancer what needs to change to ensure better outcomes for children diagnosed with astrocytoma in the future.

Research has revealed that nine out of ten UK supermarkets lack any policies to measure total supermarket sugar sales across all products and set reduction targets.

First in a series of five articles, Norm Buckley and Jason Busse explore the trials and tribulations associated with using opioids for chronic pain, particularly in Canada.

This paper describes why the fee system for acute care hospital reform in Japan is beginning to show results.

Professor Y-h. Taguchi uses tensor decomposition to identify genes associated with altered gene expression caused by drug treatment.

In this interview, Benyamin Rosental, PhD, from the Shraga Segal Department of Microbiology, Immunology, and Genetics, looks toward hexacorallian models to transplant stem cells to corals affected by global warming.